Acute myeloid leukaemia (AML): treatment of the older patient
- 31 March 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 14 (1) , 139-151
- https://doi.org/10.1053/beha.2000.0120
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Long-term survival in acute myelogenous leukemiaCancer Genetics and Cytogenetics, 1994
- The treatment of acute myeloid leukaemia preceded by the myelodysplastic syndromeLeukemia Research, 1992
- AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trialBritish Journal of Haematology, 1989
- Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaBlood, 1989
- Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemiaBritish Journal of Haematology, 1988
- Clonal Development, Stem-Cell Differentiation, and Clinical Remissions in Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1987
- High-Resolution Chromosomes as an Independent Prognostic Indicator in Adult Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1984
- Clinical Significance of Chromosomal Abnormalities in Acute Nonlymphoblastic LeukemiaCancer Genetics and Cytogenetics, 1984
- General reportCancer Genetics and Cytogenetics, 1980
- CHROMOSOME CHANGES IN ACUTE LEUKAEMIABritish Journal of Haematology, 1980